I don’t think big funds determine what’s a fair sell price based on what it takes to break even on any particular investment. Having said that, I don’t disagree that they’d want a substantial premium to current market value
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025